Afficher la notice abrégée

dc.contributor.authorRios Fernández, Raquel
dc.contributor.authorCallejas Rubio, José Luis 
dc.contributor.authorSánchez-Cano, Daniel
dc.contributor.authorOrtego Centeno, Norberto 
dc.date.accessioned2025-01-28T11:39:42Z
dc.date.available2025-01-28T11:39:42Z
dc.date.issued2018-09
dc.identifier.citationRios-Fernández R, Callejas-Rubio JL, Sánchez-Cano D, Ortego-Centeno N. Low-Dose Rituximab for Hemolytic Anemia Retreatment in a Patient With Systemic Lupus Erythematosus. Am J Ther. 2018 Sep/Oct;25(5):e577-e578. doi: 10.1097. (IF: 2.69; Q3)es_ES
dc.identifier.urihttps://hdl.handle.net/10481/100748
dc.publisherAm J Theres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleLow-Dose Rituximab for Hemolytic Anemia Retreatment in a Patient With Systemic Lupus Erythematosuses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1097/MJT.0000000000000658


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional